Organigram Global (OGI) Operating Income (2018 - 2026)
Organigram Global's (OGI) quarterly Operating Income came in at -$13.9 million in Q1 2026, down 162.32% year-on-year from $22.2 million in Q1 2025, and down 357.76% on a QoQ basis from $5.4 million in Q4 2025.
Organigram Global (OGI) Operating Income (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has 7 years of Operating Income data on file, last reported at -$13.9 million in Q1 2026.
- On a quarterly basis, Operating Income fell 162.32% year-over-year to -$13.9 million in Q1 2026; TTM through Mar 2026 was -$18.6 million, a 16.68% increase from a year earlier, with the FY2025 full-year figure at -$8.5 million, changed N/A from the prior year.
- Operating Income for Q1 2026 stood at -$13.9 million, down from $5.4 million in the prior quarter.
- Over the last five years, Operating Income for OGI reached as high as $5.4 million in Q4 2025 and fell as low as -$13.9 million in Q1 2026.
- Historically, Operating Income has averaged -$4.7 million across 3 years, with a median of -$5.1 million in 2024.
- Across the five-year window, Operating Income surged 210.47% in 2025 and tumbled 162.32% in 2026, its largest moves.
- Year by year, Operating Income stood at -$4.9 million in 2024, then jumped by 210.47% to $5.4 million in 2025, then plunged by 357.76% to -$13.9 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were -$13.9 million in Q1 2026, $5.4 million in Q4 2025, and -$5.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Organigram Global | 119.01 Mn | 152.08 Mn | 28.97 Mn | -13.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.86 Mn |
| Dec 31, 2025 | 5.38 Mn |
| Mar 31, 2025 | -5.28 Mn |
| Dec 31, 2024 | -4.87 Mn |
| May 31, 2021 | -69.70 Mn |
| Feb 28, 2021 | 57.49 Mn |
| Nov 30, 2020 | -28.21 Mn |
| Aug 31, 2020 | -185.07 Mn |
| May 31, 2020 | -71.02 Mn |
| Feb 29, 2020 | -4.03 Mn |
| Nov 25, 2019 | 15.25 Mn |
| Aug 31, 2019 | -20.95 Mn |
| May 31, 2019 | -8.43 Mn |
| Feb 28, 2019 | -1.77 Mn |
| Nov 30, 2018 | 46.25 Mn |
| May 31, 2018 | 7.77 Mn |